News

Bone loss could affect as many as 31 percent of SLE patients. This article sums up the treatment options from first-line bisphosphonate recommendations to emerging treatments like abaloparatide.

Doctors, remember that pain is subjective and may not fall easily into a grading system, writes Dr. Irina Litvin, a rheumatology fellow at SUNY Downstate in Brooklyn, N.Y.

All patients about to undergo surgery should be preoperatively evaluated for fall history, a study shows.

Low protein intake may be responsible for fractures in older men, according to an observational study.

Using biomarkers to assess drug efficacy could pave the way for improved osteoporosis treatment, according to a new study.

Assessing the elevated risk of aortic aneurysm in rheumatoid arthritis.

A retrospective analysis of patient records has found a significant link between psoriatic arthritis and malignant cancer – particularly breast cancer.

Tumor necrosis factor inhibitors have transformed the treatment of psoriatic arthritis. However, switching TNF inhibitors two or three times is not uncommon.

Epidemiological evidence points to an intimate relationship between intestinal inflammation and joint inflammation, such as psoriatic arthritis.

The authors say that for uveitis “there is a large unmet medical need" for identifying other therapies. Adalimumab is associated with decreased visual impairment and decreased risk of uveitic flare, but more adverse events, according the results from a recent multinational phase 3 trial.

Will our next president be medically fit? And how much is the public entitled to know about candidates’ personal health?

Marijuana use is up as is concern over laced cannabis. Dr. Litvin shares her account of a patient self-medicating with a non-medical grade marijuana leading to negative outcomes.

Chronic back pain may not be as it seems. Many patients suffer for years before being diagnosed with axial spondyloarthritis.

Retrospective study results indicate that golimumab may be a new and effective choice for maintaining remission and preventing recurrence of severe, recurrent anterior uveitis in patients with HLA-B27-positive ankylosing spondylitis.

A small British study indicates that the use of several immunosuppressive agents can restore the effectiveness of ustekinumab (Stelara) in patients with psoriasis and psoriatic arthritis.

“Physical exercise is an essential component of any treatment for fibromyalgia, and plenty of studies have demonstrated that low-impact aerobic exercise offers the most benefits," said Jamil Natour, MD, PhD.

Cushingoid appearance is a side effect of glucocorticoid use, but to date, there has been little knowledge about how glucocorticoids can change fat mass and redistribution.

A new study finds that slightly more than one-third of the patients were adherent to their index biologic and almost half discontinued within 12 months of initiation of therapy.

While it has been known for some time that psoriasis patients are at increased risk of developing cardiovascular disease and other comorbidities, new research has shown that these patients also have a higher risk of developing aortic aneurysms.

Many psoriasis patients wish they were better informed of the significant impact their skin condition would have on their physical and mental health, according to results from Psoriasis in America 2016, a Health Union national survey.

Identifying quality indicators will be important under MACRA. Some say quality indicators are true measurements that reflect the standard of care.

The blistering pace of mobile innovation has opened countless doors for clinical application. Built on Apple's ResearchKit platform, GSK's PARADE app seeks to study rheumatoid arthritis patients in their daily lives.

Patients afflicted with severe psoriasis may be at higher risk for chronic pancreatitis (CP).

Rheumatology nurses play an important role in identifying patients who may have hypermobility, a condition marked by painful joints capable of a long range of motion, says Dr. Rodney Grahame who spoke at RNS16.

Analysis of data from 2 large trials finds that cutoffs used to separate different “disease activity states” on the Disease Activity index for Psoriatic Arthritis (DAPSA) are valid. Different disease activity states are associated with different degrees of functional impairment and joint damage progression.

In this Q&A, Rheumatology Network speaks with Dr. Barbara Vilen who is making strides in both basic and translational research that may lead to new therapeutic targets for lupus.

In this Q&A, Rheumatology Network speaks with Dr. Stephen Katz about the NIAMS Action Plan for Lupus Research.

Observed improvements were not statistically significant above placebo, and there remains no approved medication for adolescent sufferers of fibromyalgia.

With the hope of wasting less time on medications doomed to fail, researchers are seeking biomarkers to predict a patient’s response to particular RA treatments.

In this article, we ask the experts to share their thoughts on the roots of doctor-patient communication challenges. Overwhelmed patients, busy doctors and technological communication rose to the top.